Switchpoint Bio is decoding the molecular switchpoints that drive human health and disease. The choices our cells make — which genes to activate, how to respond to environment and exposure, when to mount immune defenses — are governed by epigenetic mechanisms we're only beginning to read. We bring together genomics, epigenomics, and AI to turn complex biology into decision‑grade evidence for drug discovery and clinical decision‑making.

The stakes are real. Epigenetics is how cells record genetics, aging, environment, and exposure across a lifetime — and it shapes nearly every major area of human disease. Our flagship programs focus on autoimmune conditions and cancer today, but the same mechanisms underlie cardiovascular, metabolic, and neurodegenerative disease. Together, these touch billions of lives — yet most treatments are still chosen by trial and error. We're building the platform that makes these mechanisms visible — and the evidence base that turns it into better...